Bayview Pharmacy is pleased to provide a compounded oral suspension of Carbidopa 1.25 mg/ml/Levodopa 5 mg/ml. This formulation is specifically designed to manage Parkinson's disease, restless leg syndrome, and other movement disorders. It is a combination of two potent medications, Carbidopa and Levodopa, which synergistically work to alleviate the symptoms associated with these conditions.

Carbidopa functions by reducing the breakdown of Levodopa in the body, thereby allowing a greater amount of the medication to reach the brain and effectively reduce symptoms. Levodopa, on the other hand, is the active ingredient that directly combats the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement.

This compounded formulation is a proven treatment for Parkinson's disease, restless leg syndrome, and other movement disorders. However, it is crucial to note that this formulation is contraindicated in patients with narrow-angle glaucoma, or those who are currently on monoamine oxidase inhibitors (MAOIs). Additionally, patients should be informed that this formulation may induce drowsiness, and as such, they are advised not to drive or operate heavy machinery until they fully understand how the medication affects them.

If you have any inquiries about this formulation or how it can aid in the treatment of Parkinson's disease, restless leg syndrome, or other movement disorders, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you.

Carbidopa 1.25 mg/ml/Levodopa 5 mg/ml Oral Suspension is a compounded formulation specifically designed for the treatment of Parkinson's disease. This medication is a liquid dosage form, ensuring a uniform dispersion of the active ingredients for effective administration. However, it is crucial to note that this formulation is not suitable for patients with narrow-angle glaucoma, severe liver impairment, or end-stage renal disease.

Patients should be aware that this medication may cause side effects such as drowsiness, dizziness, or lightheadedness. It is advised not to drive or operate machinery until the effects of this medication are fully understood. Additionally, this formulation may cause gastrointestinal symptoms such as nausea, vomiting, or diarrhea. If these symptoms persist or worsen, it is important to contact a healthcare provider immediately.

Furthermore, this formulation may interact with other medications, including but not limited to antacids, iron supplements, and certain antibiotics. It is essential to consult a healthcare provider before starting any new medications while on this treatment. This formulation may also interact with certain foods, particularly dairy products. Therefore, it is recommended to discuss dietary restrictions with a healthcare provider before consuming any potentially interacting foods.

It is important to remember that each patient's response to medication can vary, and regular follow-ups with a healthcare provider are necessary to monitor progress and adjust the treatment plan as needed. If you have any questions or concerns about this medication, please do not hesitate to reach out to your healthcare provider.

Carbidopa 1.25 mg/ml/Levodopa 5 mg/ml Oral Suspension is a compounded formulation designed to manage the symptoms of Parkinson's disease. This combination medication works by increasing the levels of dopamine in the brain, a neurotransmitter that plays a crucial role in coordinating movement and balance. The presence of Carbidopa in this formulation aids in preventing the breakdown of Levodopa in the body, thereby ensuring more of it reaches the brain to exert its therapeutic effect.

This oral suspension is typically administered twice daily, and can be taken with or without food. It is crucial to adhere to the prescribed dosage and schedule set by your healthcare provider. Avoid altering the dosage or discontinuing the medication without prior consultation with your doctor, as this could lead to adverse effects or a resurgence of symptoms.

Common side effects associated with this medication include nausea, vomiting, dizziness, and headaches. If you experience any of these or other side effects, it is important to contact your healthcare provider immediately. It's also crucial to inform your doctor of any other medications you are currently taking, as there may be potential interactions.

At Bayview Pharmacy, we are committed to providing comprehensive information and support for all your medication needs. If you have any questions or concerns about Carbidopa 1.25 mg/ml/Levodopa 5 mg/ml Oral Suspension, or any other medication, please do not hesitate to reach out to us.

Carbidopa 1.25 mg/ml/Levodopa 5 mg/ml Oral Suspension is a compounded formulation designed to treat a variety of neurological conditions. This includes, but is not limited to, tardive dyskinesia, Huntington's disease, and Tourette's syndrome. This formulation may also be beneficial in managing symptoms of mental health conditions such as depression and anxiety. Furthermore, it can be used to alleviate symptoms of drug-induced extrapyramidal reactions, including akathisia, dystonia, and parkinsonism. It is crucial to understand that this formulation should only be used for the conditions mentioned above unless otherwise directed by a healthcare professional. If you have any queries regarding the use of this formulation for any other condition, please consult with a healthcare provider.